CBIO
Catalyst Biosciences Inc
Halal Rating :
Last Price
$10.95
Last updated:
Market Cap
-
7D Change
9.61%
1 Year Change
-43.26%
Company Overview
Exchange
Next Earnings Date
Catalyst Biosciences Inc is a biotechnology company focused on leveraging its protease engineering platform to develop innovative treatments for rare diseases in the areas of hemostasis and complement diseases. The company has historically worked on developing treatments for hemophilia and other rare bleeding disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $25.49m | $20.73m | - | $-523000.0 | 0.00% | 2.52% |
| June 30, 2024 | $25.23m | $21.68m | - | $-350000.0 | 0.00% | 1.61% |
| March 31, 2024 | $27.17m | $18.77m | - | $-328000.0 | 0.00% | 1.75% |
Company Impact
Help us evaluate Catalyst Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.